Target intelligence / Profile preview

Aquaporin‑1 (AQP1)

Target
AQP1
Molecular classification
Water channel protein, Integral membrane protein, Tetrameric channel, Major intrinsic protein (MIP) family, Transporter
01

Overview

Aquaporin‑1 is a tetrameric integral membrane protein, with each monomer comprising six transmembrane α-helices connected by five loops (two extracellular, three intracellular), and containing the highly conserved asparagine-proline-alanine (NPA) motifs responsible for water selectivity[1][2][4][6][3][7]. It is found in erythrocytes, kidney, vascular endothelium, and the central nervous system, facilitating rapid osmotic water flux and contributing critically to fluid balance in mammals. The channel operates via a single-file water transport mechanism with size-exclusion selectivity, preventing proton and ion leakage[2][6][7]. In some cases, the central pore of the tetramer may exhibit limited ion conductance[2][4]. Aquaporin‑1’s activity can be modulated by small molecules and post-translational modifications, providing possible avenues for therapeutic intervention in diseases linked to abnormal water transport[5][1]. In summary: Aquaporin‑1 (AQP1) is a prototypical water channel protein, playing vital roles in physiology and disease, and remains a focus of therapeutic research for managing water balance disorders.

Other names
CHIP28 (Channel-like integral membrane protein 28 kDa)Colton blood group antigen
02

Mechanism of action

Inhibitors block water permeability by interacting with cysteine residues near the pore (Cys-189), such as mercurials

03

Biological functions

Facilitation of transmembrane water transportMaintenance of cellular osmotic balanceFluid reabsorption (e.g., in kidney proximal tubule)Nonselective cation channel gate by cGMP (limited evidence)
04

Disease associations

EdemaGlaucomaCancerDisorders of ocular fluid movementCardiovascular dysfunction
05

Safety considerations

Potential impairment of water homeostasis, leading to dehydration or fluid retentionRisk of systemic side effects due to broad tissue expressionChallenges in selective targeting due to conserved structure among aquaporin family members
06

Interacting drugs

No drugs are currently approved specifically targeting Aquaporin‑1, but mercurial compounds (e.g., HgCl₂) can inhibit its function in experimental models
07

Biomarkers

Expression levels of AQP1 may serve as biomarkers for tumor progression (certain cancers), edema prediction, or kidney function monitoring

Beyond the preview

Go deeper on Aquaporin‑1 (AQP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaporin‑1 (AQP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call